Whoop pushed back on the warning letter, claiming its blood pressure feature for a wearable wristband is for “wellness” and ...

Sarepta stock crashed Friday on reports the FDA will ask the biotech company to stop shipments of its approved gene therapy, ...

Milestone Pharmaceuticals' recent $52.5 million equity raise was poorly timed and dilutive, but it ensures its survival even ...

The FDA's decision will offer a new lease of life to the company, which came close to filing for bankruptcy following a federal ban in 2022, despite links to cancer.

Genentech, part of the Roche Group (OTCQX:RHHBY) (OTCQX:RHHBF) (OTCPK:RHHVF), announced that the U.S. FDA has rejected its request to expand the use of its cancer drug Columvi. The company had applied ...

The 2000s were a mix of pop punk, flip phones, and drinks that gave you wings—and maybe a few bad decisions. While energy ...

The analyst further reasoned that the high ocular toxicity rates, including keratopathy and visual acuity changes, are especially alarming, as a majority of the patients experienced severe and ...

Despite this backdrop, Royalty Pharma continues to distinguish itself through its unique business model, which centers on ...

In early research, OCU410ST, a gene therapy for Stargardt disease, demonstrated slowed lesion growth by 48% at the 12-month follow-up in evaluable treated eyes.